News

Search:

UK Regulators Warn Consumers about Risk of Mercury, Lead in some Herbal Medicines

0 Likes

UK regulators sent out a warning to the public on 19 February 2013 regarding what they said was the potential for consumers to be poisoned by unlicensed Chinese medicines imported into the country.At Read More...

Tags:

Contamination

Herbal

Lead

Mercury

MHRA

Purity

Warning

Final Guideline on Antibiotic Impurities Focuses on Manufacturing Processes

0 Likes

The European Medicines Agency (EMA) has released final its final guideline on how to set specifications for impurities present in antibiotics not covered by other internationally-harmonized Read More...

Tags:

antibiotics

EMA

Fermentation

Guideline

Impurities

Purity

USP Releases Overhaul of Impurities Testing Standards

1 Likes

The US Pharmacopeia (USP), a standards-setting body for the content of medicines, has released two new standards to limit the presence of elemental impurities in medicinal products.The standards, Read More...

Tags:

<231>

<232>

<233>

API

drug

Excipient

Impurities

Pharmaceutical

Purity

Standards

Toxicity

USP

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

UK Regulators Warn Consumers about Risk of Mercury, Lead in some Herbal Medicines

Final Guideline on Antibiotic Impurities Focuses on Manufacturing Processes

USP Releases Overhaul of Impurities Testing Standards

Get RF Today